One of the nation’s largest health insurers will use “step therapy” in some of its private Medicare plans next year, requiring patients to try cheaper drugs before pricey biologics and other costly medicines. The decision by UnitedHealthcare is among the first signs that insurers plan to take advantage of a Trump administration initiative that policymakers argue will bring down drug costs for consumers. (Ike Swetlitz, STAT)
